Laura Caflisch

Statistics

Publications

Citations

213

H-Index

Active since

2013

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Texas Oncology

Laura Caflisch is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, glioblastoma trials, and pharmacology.

ORCID

Publications per year

2013–2023

Publications

Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma

William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek et al. · Clinical Cancer Research · 2023 · 117 citations · Full text

Medicine, Oncology, Pharmacology +15

The C. elegans Male Exercises Directional Control during Mating through Cholinergic Regulation of Sex-Shared Command Interneurons

Amrita L. Sherlekar, Abbey Janssen, Meagan S. Siehr et al. · PLoS ONE · 2013 · 52 citations · Full text

Life Sciences, Biology, Neuroscience +17

Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study

Andrew Brenner, Richard Zuniga, Jessica D. Sun et al. · Neuro-Oncology · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

Prospective phase II trial in patients with first relapse of high-grade astrocytoma using TVB-2640 in combination with bevacizumab versus bevacizumab alone.

Brandon Konkel, Laura Caflisch, Adolfo Enrique Diaz Duque et al. · Journal of Clinical Oncology · 2019 · 10 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4